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CHAPTER I

INTRODUCTION
Candida albicans (Robin) Berkhout is a moniliaceons fungus of the
subfamily Cryptococcoideas, which can exist as a budding yeast-like
cell (blastospore) or a branched pseudomycelium with whorled blastospores and terminal chlançrdospores. Under "normal" conditions, the
organism exists as a saprophyte on the skin and raucous membranes of
man. Ç. albicans can, however, under certain conditions, become
mycelial in the host and assume the role of a pathogaa.
"Bie recognized pathogenicity of £. albicans dates back to the midnineteenth century at which time it was reported to be implicated in
oral thrush (Langerbeck, 1839) and vaginitis (Wilkinson, 18^9)'
Since the early 19U0's, clinical candidal infections have been
reported on the increase (Kashkin et al^., 1961) and systemic candidosis
has become a recognized diagnostic and therapeutic problem (Wolfe and
Henderson, 19^1; Pearl and Sidransky, I960; Hyun and Collier, I960;
Kay et al., 1961). Prom 19U0 until April, 1966, there were hi reported
cases of candidal endocarditis with only five reported survivals among
them (Utz, 1966). Although candidal infection of the brain, heart,
lung, and other deep structures is not common, it is important because
the infection is usually associated with a fatal outcome,
Ihe increase in candidal infections may in part be attributed to
the development of more accurate diagnostic techniques for the detec
tion and identification of the organism (Rosenthal and Rimari, 1958;
1
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Taschdjian e;t al., I960; Walker et al^., I960), However, since 19&0
antibiotics used in the treatment of bacterial infections and corti
costeroids used in correcting metabolic disturbances have been shown
to predispose an individual to a superimposed fungal infection (Kashkin
et al., 1961; Woods et al., 19l?l; Young et al., 1956).
The mechanism of antibiotic predisposition of mucous membranes
has been attributed to an inhibition of the normal bacterial flora
(which normally maintains low numbers of £. albicans by competition,
antibiosis, etc.) with a subsequent proliferation and invasion of the
mucosa by G. albicans (Gorczca and McCarty, 19^9; Isenberg et al.,
I960; Young et al., 19^6; Pain, 1958).
In the case of the corticosteroids, the mechanism of predisposi
tion has been attributed to their effect on the reticuloendothelial
system resulting in decrease in antibody production, in the inflamatory
response process, and in phagocytosis (Kass et al., 1955; Germuth and
Ottinger, 1950; Crepea et_a^., 1951; Bj^rneboe et ^., 1951; Michael
and Whorten, 1951). Corticosteroids may also affect nonspecific re
sistance (Seelig, 1966).
Certain disease processes and metabolic disorders which directly
or indirectly decrease host resistance may predispose an individual to
candidosis. A positive correlation of abnormalities of leukocyte
metabolism with impaired phagocytic capacity has been demonstrated in
cases ôf diabetes, leukemia, and corticosteroid therapy (Seelig, 1966).
Hie pathogenicity of C. albicans has been attributed to its abil
ity to invade tissues in the mycelial form (Young, 1958) and to the
production of toxic metabolites including an endotoxin (Salvin, 1952).
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%e production of chlaraydospores by G. albicans has also been associated
with the pathogenicity of the organism in endocarditis (Heineman et al.,
1961).
There have been a great many agents employed in the treatment of
superficial candidal infections: undecylenic acid (Kendall, 19h7),
various fatty acids (Van Assen, 19^0), caprylic acid (Lapan, 1959)»
gentian violet (Hesseltine, 19^5)» candicidin (Fox, 19^5), nystatin
(Jennison and Llywelyn-Jones, 19^7), and sodium caprylate (Watt et al.,
1962).

Some of these agents have been more successful and aesthetic

ally more acceptable than others. However, there were two major
problems which plagued the therapeutic use of the early antifungal
agents in cases of systemic candidosis:
a. the antifungal agent produced serious side effects in the
host;
b. the antifungal agent was toxic to the host in the concentra
tion needed to exert its fungistatic or fungicidal effects on
the fungus.
It was not until the discovery of the polyene antibiotics in 19U9
(Hazen and Brown, 19^0) and more specifically amphotericin B in 19^6
(Gold et al., 19?6) that there appeared an effective agent for the
treatment of systemic candidosis with a minimal incidence of serious
side effects in the afflicted host.
Amphotericin B was isolated from Streptomyces nodosus, idiich was
recovered from a soil sample in the area of the Orinoco River in Vene
zuela (Gold et al., 19^6). ïhe antibiotic was characterized physically
and chemically in 195& (Vandeputte et al., 19^6; Donovick et al., 19^6).

h
The mode of action of amphotericin B has been attributed to its
ability to bind to the cell wall and cell membrane which subsequently
results in an alteration in cell membrane permeability. Accompanying
this alteration in cell membrane permeability is a loss of anions,
cations and acids of the citric acid cycle. Terminally, cell respira
tion and glycolysis cease (Marini e;t al., 1961; Kinsky, I96I5 Gale,
I960).
The primary problem which had to be overcome in order for ampho
tericin B to be used therapeutically was its insolubility in water.
Riis problem was overcome without loss of fungicidal activity by complexing amphotericin B with sodium desoxycholate (Louria, 19^8j Bartner
et al., 19^8).
Amphotericin B has been used successfully in the therapeutic
treatment of candidal endocarditis (Prinsloo and Pretorius, 1966;
Kroetz et al., 1962), meningitis (Parillo et al., 1962) and septicemia
(Sweeney and Dineen, I960; Louria and Dineen, I960). However, in some
cases where a concentration of the antibiotic which inhibited growth
of 2» albicans in vitro was reached, it appeared to be ineffective in
combating the ssrstemic candidal infection (Kay et al., 1961).
Concentrations of amphotericin B given intravenously in excess of
1.Ç mg/kg generally produce serious side effects which may adversely
affect the outcome of the treated infection.
Hie present research problem is addressed in part to the questions
Has Candida albicans resistance to concentrations of amphotericin B
which would be toxic in a systemic human infection?
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Iiones and Peacock (19^9), Sorenson et al, (19?9), Littman et al,
(I9^8a), Lepper et al. (1959), Seabary and Dascotnb (1958), Hebeka and
Solotorovsky (1965) and Utz et al^. (1959) have investigated the inhibi
tory effects of amphotericin B on £. albicans»

The concentrations

which were reported to be fungistatic ranged from 0.2 to 3.7 /ig/ml
(Seabury and Dascomb, 1958; Littman et al.. 1958a). Such wide varia
tion may have been expected since most of the reports cited differed
in the assay medium used for the determination of the minimal inhibitory
concentration, the number of organisms used in the assay, the time after
which the inoculated assay tubes were read, the method used to determine
the per cent of inhibition of amphotericin B on £. albicans and the
defined inhibitory point measured.
Littman was the only investigator of those cited who reported a
fungicidal dose of amphotericin B for a strain of G. albicans. This
observation formed the basis for the second part of the research problems
the determination of the fungicidal concentration of amphotericin B for
6 clinical isolates of £, albicans.
In the selection of naturally occurring resistant mutants to
amphotericin B, Lones and Peacock (1959) reported that 12 strains of
G^. albicans grown for 52 serial transfers in culture media containing
graded concentrations of amphotericin B all experienced an increase in
tolerance to the antifungal agent. Accompanying this increase in toler
ance to amphotericin B was a depressed growth rate among the derived
strains and a decreased ability to form mycelium and chlamydospores on
com meal and rice-polysorbate 80 medium. This observation formed the
basis for a third area of research to be considered in this investigations

6

Does tolerance to amphotericin B result in a decrease in the ability
of £. albicans to produce the characteristics associated with the
pathogenicity of the parent strain, i.e., yeast-mycelium transformation
and chlamydospore production?
Finally, the author wished to determine the effect of amphotericin
B on an immunologically depressed host and to determine if there is any
correlation between immunological depressed, and the outcome of the
amphotericin B-treated systemic candidal infection.

CHAPTER II

STATEMENT OF PROBLEM
Candida albicans is a moniliaceous fungus which may assume the
role of a systemic pathogen. This study was undertaken (l) to investi
gate the fungistatic and fungicidal properties of amphotericin B on
C. albicans; (2) to determine if characteristics associated with the
pathogenicity of £. albicans are affected by exposure of £. albicans
to fungistatic amounts of amphotericin B, and (3) to determine if a
decreased host resistance affects the outcome of an amphotericin Btreated candidal infection.

7

CHAPTER III

METHODS AND MATERIALS
Organisms Bnployed
Six strains of Candida albicans which were isolated from clinical
cases of vaginitis were employed in this investigation. %e
strains were designated IB, 2A, 3A, ^A, 60, and 7A, respectively.
Isolation of the Organism
Primary isolation of the clinical isolates was made on PaganoLevine medium (Pagano et al., 19^8). Colonies which appeared
creamy-white or faintly pink in color (Gillespie et al., I960)
were transferred to Sabouraud dextrose broth and then restreaked
for isolation on Pagano-Levine medium.
Identification of the Isolates as Candida albicans
Bïe identification of the isolates as Candida albicans was based
on the appearance of the organisms on Sabouraud agar, blood agar,
and com meal agar with \% TVeen 80 (Walker et

, I960). The

ability of the organisms to produce germ tubes in human serum
within h hours (Taschdjian e^ al., I960) and agglutinate in G.
albicans antiserum (Rosenthal and Pamari, 1958) were also con
sidered as criteria for the establishment of the identity of each
isolate. If an isolate appeared as a white opaque budding yeast
on Sabouraud and blood agar within U8 hours, produced a pseudonycelium with whorled blastospores and terminal chlamydospores on
8
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com meal agar with 1% T»een 80, produced germ tubes in human
serum within ii hours and agglutinated in £. albicans antiserum,
the isolate was identified as £. albicans»
(U) Culture Media
Stock cultures of £, albicans were grown and maintained on modi
fied Sabouraud agar (2% glucose, \% peptone, 1.?^ agar) which was
buffered to pH 7 with 2N NaOH. After incubation of the inoculated
Sabouraud slants at 37°G for I4.8 hours, they were refrigerated at
and a duplicate frozen at -80°G. The refrigerated stock cul
tures were transfered monthly and periodically checked for contam
ination microscopically and by streaking on blood agar.
Modified Sabouraud agar made up in .001 M potassium phosphate
buffer to pH 6.7 was used as the medium for all viable cell
counts.
Com meal agar with \% Tween BO was prepared by adding 17 gm of
(Difco) com meal agar to 990 ml of distilled water. Hie medium
was then heated until all components were completely dissolved.
Before autoclaving the medium, 10 ml of Tween 80 were added to
the flask.
Modified Sabouraud broth which was made up in 0.001 M potassium
phosphate buffer to pH 6.7 was used as an assay medium.
Trjrpticase soy broth was prepared according to the BEL Manual
(Baltimore Biological Laboratory, Inc., Baltimore, Maryland, 19^6).
Blood agar was prepared by adding SO ml of sterile human blood
aseptically to a liter of trypticase soy agar which, after having
been autoclaved was cooled to $0°C in a water bath. %e mixture

10

was swirled to obtain a uniform distribution of the blood and
then dispensed into sterile petri plates and allowed to solidify.
Pagano-Levine agar was prepared according to the Difco Literature
Supplement (196U).
Human plasma was obtained by centrifugation and filter-steriliza
tion of outdated unhemolyzed human blood obtained from the blood
bank of Saint Patrick Hospital, Missoula, Montana.
(5) Chemicals
Hydrocortisone acetate was obtained as a sterile suspension from
Towne, Paulsen and Company, Inc., Monrovia, California. The
suspension which contained 2^ mg/ral was used undiluted directly
from the vial as recommended by the pharmaceutical company.
Amphotericin B* was obtained as a sterile lyophilized powder from
E. R, Squibb and Sons, New York. Each vial contained $0 mg of
amphotericin B which was coraplexed with sodium desoxycholate
(Bartner e^a^., 19^8). "Rie amphotericin B was refrigerated and
reconstituted with sterile distilled water just prior to use.
The hydrated unused amphotericin B was stored at $°C for no longer
than one week or frozen at -20°C and kept for no longer than three
weeks.
Neomycin sulfate and triphenyl tetrazolium chloride were obtained
in powder foiro from Nutritional Biochemical Corporation.

* The trade name of E, R. Squibb and Sons for amphotericin B
Fungizone.
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Mice
Mice used in this investigation were male adult white mice of the
HML strain obtained from the Rocky Mountain Laboratory, U.S.P.H.S,,
Hamilton, Montana. Ihe average weight of the mice used in the
investigation was 28,? gm.
Cîounting Method
Five 1:10 serial saline dilutions were made of a cell suspension
standardized to 60$ transmittance at a wave length of 660 mu.
One-tenth ml aliquots of the standardized suspension were pipetted
in duplicate from each dilution on to modified Sabouraud agar.
The inoculum was uniformly spread over ttie surface of the agar
with a sterile bent glass rod (hockey stick), Ihe plates were
inverted and incubated at 37°G for 1^8 hours. After incubation,
colonies were counted with the aid of a Coulter colony counter
and the number of organisms per ml calculated.

CHAPTER IV

EXPERIMENTAL PROCEDURES AHD RESULTS
Bicperlment 1. Determination of the fanglstatic and fungicidal dose of
amphotericin B for six strains of £. albicans.
Forty-eight hours prior to the start of the investigative procedure,
each of the 6 strains of £. albicans was inoculated on modified Sabouraud agar and incubated at 37°C,
Screw-capped tubes, 16 x 1^0 mm, were filled with 8.5 ml of modi
fied Sabouraud broth. Ihe tubes were autoclaved at 1^ psi for 1$
minutes, and then refrigerated until just prior to use.
Immediately before use, 1 ml volumes of the desired concentration
of the amphotericin B were added to the test tube series bringing the
total volume before inoculation of the test strain of G. albicans to
9.5 ml.
Efeich strain of jC. albicans was washed from a U8-hour slant culture
with physiological saline (0.85# NaCl). Each washed cell suspension
was placed in a calibrated 16 x 150 mm screw-capped tube and inserted
into a Coleman Model 6A spectrophotometer. The cell suspension was
adjusted to 60% transmittance at a wave length of 660 ma. After adjust
ment of the cell suspension, 0.5 ml was used as inoculum. Each series
was run in duplicate.
Viable cell counts of the standardized cell suspensions were made
on modified Sabouraud agar.
The optical density of all tubes was recorded at time zero and
12
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Table I, Effects of amphotericin B on growth of 6 isolates of Candida
albicans in modified Sabonraud broth.

Concentration of
Amphotericin B
(jigM)

IB

2A

Isolates examined
'
3A
$A
60

7A

0.1

65.7*

38,6

6I1.5

22.6

83.3

87.2

0,2

10.9

22.6

12.6

6.3

gb.7

li3.2

0.3

3.1

8.3

3.2

7.9

8.3

18.2

0,h

li.O

0.9

0.0

0.0

1.0

2,2

0.5

0.2

0.0

0.0

0.0

0.0

0,0

* O.D, experimental/O.D. control.
again in U8 hears. After U8 hours, samples from each tube were streaked
onto blood agar which was then incubated at 37°C for ^8 hours. Yeast
phase cells from positive blood agar plates were inoculated into human
serum, incubated at 37°G for k hours and than checked microscopically
for the production of germ tubes.
The results of this investigation appear in Figure 1 and Tables 1
and 2. Concentrations of amphotericin B ranging from 0.1 to Q.$ fig/ml
affected the growth of the 6 strains of C. albicans to different de
grees; however, all 6 strains were inhibited by 0.5 ;ig/ral of ampho
tericin B.
With the method cited above and the concentrations of amphotericin
B employed, a fungicidal concentration of amphotericin B could be
demonstrated for only one of the 6 strains of G. albicans «
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Table II. Effects of amphotericin B on viability of Candida albicans
in modified Sabouraud broth, li8 hr,, 37®C.

Concentration of
Amphotericin B
()ig/ml)

Isolates examined
IB

2A

3A

60

7A

0.1

+*

+

+

+

+

+

0.2

+

+

+

+

+

+

0.3

+

+

+

+

+

O.ii

+

+

+

0.5

+
+

+

+

+

+

1.0

-

4-

+

+

-

+

1.5

+

+

+

+

4"

-

2.0

+

+

+

+

+

+

3.0

+

+

+

+

5.0

+

+

+

10.0**

+

+

+

•f

-

+

20.0

+

+

+

+

-

+

+

+

+

-

+

+

-

+

+

-

30.0
Uo.o

+

50.0

+

+

* + « viable organisms recovered on subculturej - • no viable
organisms recovered,
** Precipitates which appeared to be amphotericin B were noted
at concentrations greater than 10 fig/ml.
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Bcperlment 2. Determination of the effect of amphotericin B on G.
alblcails

loci

different assay media.

Sabouraud broth was modified so that the assay broths contained
2%

glucose, 1% peptone;

2%

glucose, 0.1% peptone; 0,^% glucose, 0.1#

peptone; and 0,^% glucose, 1% peptone, respectively. Except for the
composition of the assay broth, the investigative procedure was the
same as previously outlined (Experiment l). %e results of this exper
iment appear in Figure 2.
When the concentration of peptone was varied in the assay system,
a marked decrease In growth of £. albicans was noted In the low-peptone
media. This marked decrease in growth was present in both the antiblotlc-free and antibiotic-containing media. Varying the concentration
of glucose, however, did not appear to affect the growth of G. albicans
In either medium significantly.
Experiment 3. Effect of human plasma and amphotericin B on U strains
of G. albicans.
Outdated human blood was obtained from St. Patrick Hospital. The
plasma was drawn off the sedlmented cells, centrlfaged and then flltersterlllzed. After filtration, 3»h ml of sterile plasma was pipetted
into a series of 16 x 12$ mm screw-capped tubes and then refrigerated
until just prior to use. At the start of ttie Investigative procedure,
O.U ml of amphotericin B and 0.2 ml of a standardized cell suspension
of G. albicans were added to the test system. All test cell suspensions
were checked to determine if the organism was in the yeast phase. After
the Inoculated assay cultures had been incubating for 1*8 hours at 37°C,

17

2%
2%
0.5%
0.5%

Glucose, 1% Peptone
Glucose, 0.1% Peptone
Glucose, 1% Peptone
Glucose, 0.1% Peptone

05
AMPHOTERICIN

B

CONCENTRATION,

pg/m\

PlfturR 2. Effects of peptone and glucose concentrations on the
^roKth of C. albicans and the growth-inhibitory effects of amphotericin
B.
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slides were prepared from each assay tube and examined for the produc
tion of germ tubes from the initial yeast phase culture. The presence
of germ tubes in the assay cultures was inteirpreted to mean cell growth
in the presence of the cited concentration of amphotericin B, One ml
samples were also removed from each tube in the series and transfered
to a blood agar plate and Erlenmeyer flask containing 12$ ml of sterile
trypticase soy broth. The suspensions were spread over the surface of
the blood agar plates with sterile bent glass rods. "Rie blood plates
and trypticase soy broth flasks were incubated for U8 hours at 37°C
and than read for growth. Of the organisms recovered after exposure
to various concentrations of amphotericin B, representative colonies
were checked for their ability to form germ tubes in human serum within
U hours, %e results of this study appear in Tables III and 17 and
Figure 3.
"Hie fungistatic concentration of amphotericin B in plasma was
observed to be greater than in broth. However, viability of the organ
ism was lost much more rapidly in plasma than in the modified Sabouraud
broth system.

Figure 3. Effect of amphotericin B on C. albicans in human plasma:
(A) Control lacking amphotericin B
(B) 0.5 fxg amphotericin B/ml

(G) 2,0 |lg amphotericin B/ml

19
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Table III, Effects of amphotericin B on growth of Candida albicans in
huTBan plasma &8 hr., 37°C.
Concentration of
Amphotericin B
(pg/tnl)

Isolates examined
"
IB
++++#

0.0

2A

3A

'
6C

++++

++++

++++

0.5

++

++

++

4-+

1.0

+

+

+

+

3,0

-

-

-

-

1&#0

—

—

—

•

^#0

—

—

—

—

2 #0

* Degree or extent of filaméntation was rated from extensive (++++)
to none (-).
Table 17. Effects of amphotericin B on viability of Candida albicans
in human plasma, U8 hr,, 37°C,
Concentration of
Amphotericin B
(pg/ml)

IB
BAP* TSB

Isolates examined
2A
3A
BAP TSB
BAP TSB

0,0

+

0,5

+

1,0

+

+
+

2,0

+

+

3.0

+

+

U.o

-

+

5.0

-

+

BAP

60
TSB

+

+
+

+

+

+

+

-

+

-

+

-

+

-

+

+

+

+

+

+
+

* BAP • blood agar plates; TSB • trypticase soy broth,
•** + • growth in subcultures; - • no growth in subcultures; + •
both viable and non-viable cultures among replicates.

21

Experiment U. Determination of the effect of amphotericin B on m&ôelial
formation and chlamydospore production in ^ strains of £, albicans.
Com meal agar with 1^ Tween 80, was autoclaved at 15 psi for 15
minutes in 500 ml screw-capped Erlenmeyer flasks. After autoclaving
the flasks were cooled in a water bath to 50°C. After cooling, 0.6 ml
of sterile distilled water were added to the control flask, while 0.6
ml of amphotericin B were added to the test flask resulting in a final
amphotericin B concentration of 2 jag/ml in a fluid volume of 3Ô0 ml.
The media were dispensed into trisectored sterile petri plates and
allowed to solidify. Three hours after solidification, the plates were
inoculated in duplicate with 5 isolates of £. albicans which had been
previously exposed to the antifungal agent. The plates were incubated
at room temperature (2b°C) and the results recorded 7 days after inocu
lation (Table 5).
There was no correlation observed between prior exposure to ampho
tericin B and the ability of the isolates to form mycelium and produce
chlamydospores on com meal-tween agar. However, there was a constant
significant reduction in nqrcelium formation among the strains of G.
albicans grown on com meal-tween agar containing amphotericin B. The
•Rie reduced mycelium formation by the strains did not appear to be
dependent on their prior exposure to amphotericin B.

Table 7. M'fects of previous and concurrent exposure to amphotericin B on growth and
chlançrdospore formation by Candida albicans on com meal agar.

Com meal-Ikeen 80 agar
ial
Chlangrdospore
h
production

Com meal-Rfeen 80 agar
with amphotericin B
Mycelial
Qilami^ospore
production
growth

IB-P
IB-Al
1B-A2

0
10
10

+++
+++
+++

+++
+++
+++

+
+
+

2A-P1
2A-P2
2A-A1
2A-A2
2A-A3
2A-AU
2A-A!i

0
0
0
10
10
20
20
20
20

+++
+++
+++
+++
+++
+++

+++
+++

++
+++
++

3A-P
3A-A1
3A-A2
3A-A3

0
10
10
10

+++
+++
+++
+++

+++
+++
+++

5A-P
5A-A1
5A-A2

0
10
10

+++
+++
+++

+++
+++
+++

•f

+++

+

+++

7A-P
7A-A1
7A-A2

0
10
20
20

+++
+++
+++

+++
+++
+++

+++

+++

+++
+++

+++
+++
+++

+
+++

+++
+++
+++

+++

+f+
+f+
+++

*>ig amphotericin B/ml of modified Sabouraud broth, 1^8 hr., 37°C.

++

23

Bgpertment

Effect of hydrocortisone acetate on an experimentally

Induced systemic candidosis.
Rocky Mountain Laboratory white mice were used in this study to
determine the effects of hydrocortisone on the course of an experiment
ally induced systemic candidosis. The treated mice received 1.2^ mg of
hydrocortisone intraperitoneally daily for k days prior to being chal
lenged with G. albicans isolate 3^. A saline suspaision of the chal
lenge dose, 1 X 10^ cells, was given intravenously in 0,1 ml. The
composition of the various groups in this experimental study were as
follows: 13 cortisone-treated, challenged mice; 8 challenged control
mice; 7 cortisone-treated, unchallenged mice; and 2 saline-treated,
control mice. "Hie results of this experiment (Figure k) clearly show
that hydrocortisone definitely decreased the animal's ability to con
trol the systemic candidosis. Autopsies were randomly performed to
verify the cause of death. In some animals kidney lesions were more
evidant than in others.
There was one death which occurred among the hydrocortlsonetreated, unchallenged mice. It occurred on the 11th day after hydro
cortisone treatment was discontinued and was attributed to cannibalism.
Earlier in the experiment two mice in the same group had incurred
inflicted injuries to their hind quarters and were removed and isolated.
They recovered from their wounds and survived until the termination of
the investigation.
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Experiment 6. Determination of the effect of immanological depression
on the ogtcome of an amphotericin B-treated systemic candidal infection.
Male Rffli white mice weighing from 2^ to 30 gm were used in this
investigation. Each group consisted of 9 mice with the exception of
^ cortisone-treated control mice and 3 saline-treated control mice.
Pretreatment of the mice with hydrocortisone acetate was carried out
according to the procedure outlined in Experiment ?. The procedure was,
however, modified in so far as the mice were challenged with C. albicans
strain 3A shortly after receiving their final dose of hydrocortisone.
The reason for this modification was to allow for the establishment of
the systemic infection at a point of greatest immunological depression.
Bie treated mice received 1 rag of amphotericin B 2k hours after chal
lenge and then 0.5 mg every 1*8 hours for 6 days. On a rag/kg basis each
mouse received approximately I^O and then 20 mg/kg, respectively» Autop
sies were randomly performed and the kidneys examined for macroscopic
lesions. When the cause of death was in doubt, cultures of the kidneys
were made. Bie results of this investigation appear in Figures 5 and 6.
Hydrocortisone was again shown in this investigation to decrease
the ability of the infected mice to control the systemically-induced
candidal infection. Treatment of both the cortisone- and saline-pretreated infected mice with amphotericin B showed that the response of
both groups to the antibiotic was an arrest of the induced candidal
infection. Figure 6 shows that there was approximately a h!k% fatality
due to the doses of amphotericin B employed among the control animals
which may account for and/or .contribute to the deaths observed in the
infected-treated groups.
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Figure g. Effect of amphotericin B on the course of a systeraically-induced candidal
infection in mice pretreated with hydrocortisone acetate. Mice received the following
injections; hydrocortisone acetate, cells, a ; saline, cells, * ; hydrocortisone acetate,
cells, amphotericin B, m ; saline, cells, amphotericin B, it . (See text for injection
schedule).
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Fi^re 6. Toxicity resulting from amphotericin B treatment in infected and
uninfected mice. The mice received the following injections: hydrocortisone
acetate, amphotericin B, o ; saline, amphotericin B,
hydrocortisone acetate.
saline, calls, amphotericin B,
cells, amphotericin B,

CHAPTER IV

DISCUSSION
Uie results of the to vitro broth assays of the effect of am%Aioterlcin B on C« albicans, showed that the 6 isolates of C. albicans were
inhibited to different degrees by a given concentration of amphotericin
B. Bie inhibition was partial for all isolates at 0.1 jig/nù. and com
plete for the 6 isolates at 0.5 /ig/ml. These results are similar to
those reported by Sorensen et al, (1959), Hald et al, (1957), and Littman et al. (1958a), Their method of determining fungistasis, however,
was based on a visual comparison of the assay tubes to determine growth
inhibition. The use of an increase in optical density as a criterion
for growth inhibition was considered to be a more accurate method for
determining fungistasis than that based on visual comparison.
There were other areas in the actual methods and materials employed
by Littman and coworkers (1958a)and Sorensen and coworkers (1959) which
also differed from those used in this investigation. Their use of pH 7
and inoculum size 5 z 10^ - 1 x 10^ cells compared with pH 6.7 and
inoculum size 5 x 10^ cells/ml used in this study did not appear to
significantly alter the fungistatic concentration of amphotericin B,
A comparison of the pH and inoculum size used by Hald et al. (1957)
can not be made since neither was reported.
Both Littman and coworkers (1958a) and Sorensen and coworkers (1959)
read their results after a U8-hour inoculation at 37°C. When the assay
tubes were read earlier or later, a significantly different result was
28
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reported to have occurred. Littman e^ al, (I9^8a) demonstrated that ttie
fungistatic concentration of the antibiotic varied from 0.09 p-g/ml at
2k hours to 5.0 pg/ml at the end of 7 days. Hiis alteration in the

fungistatic concentration of amphotericin B was attributed to its
deterioration in the hydrated state during prolonged incubation.
Littman*s observation may explain the low fungistatic value of 0.07

jxg/ml reported by Utz and coworkers (19$9) for 2 strains of G, albicans
after a 2lt-hour exposure to tdie antibiotic.
Based upon the work of Gold et

(1956), Vandeputte et al.

(1956), Littman et al. (1958a) and Bartner et al. (1958) a 1^8-hour
incubation period was chosen for the present studies. This period
would allow the organism sufficient time in which to grow and would
also give a more accurate picture of the fungistatic activity of
amphotericin B without allowing an unnecessary deterioration of the
antibiotic.
The assay media employed by previous investigators included Penassay broth with 1% glucose, asparagine broth and mycophil broth. Those
media and that used for assays in the present investigation appeared to
be rich enough so as not to introduce a growth limiting factor into the
assay. However, studies employing a minimal medium (0.5# glucose, and
0.\% peptone) which are reported here, demonstrated a significant de
crease in growth both in the presence and in the absence of the anti
biotic when compared to an enriched medium containing

2%

glucose and \%

peptone. The relative growth in the presence of 0.1 /ig/ml of ampho
tericin B in the rich medium was 71.2# of the control as compared to
55»3# of the control in the minimal medium. Whether the greater
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relative inhibition by the antibiotic in the low-peptone medium was a
result of the reduced peptone concentration itself or whether there was
a greater concentration of unbound antibiotic present in the minimal
medium has not been shown. A reduced glucose concentration (0.$%) in
the medium did not appear to have a significant effect on the growth
of the organism. These observations may explain in part the low fungi
static values (0.029-0.052 jig/ml) reported by Lones and Peacock (19^9)
who also used a medium containing 0.$# glucose and 0.1# peptone in con
trast to the hi^ inhibitory value (2.5jMî/ral) reported by Qainn et al.
(i960) who used a very rich medium for Ç, albicans.

An additional variable, which mast be considered in an attempt to

contrast the results of others with those of the present study, is the
specific isolate or "strain" of £. albicans employed in the assays.
That strains differ in their response to a given concentration of ampho
tericin B is demonstrated by the results of ttie present investigation
as well as that of McNall and coworkers (19^8) and Lepper and coworkers
(1959).
%e observation of fungicidal effects of amphotericin B on £.
albicans in modified Sabouraud broth demonstrated qualitatively that
cells from 5 to 6 isolates of Ç. albicans were able to survive in the
presence of an initial concentration of $0 yig/ml of the antibiotic.
Similar results were reported by Bald and coworkers (19^7) who demon
strated that viable cells were recoverable from 3 strains of £. albicans
after having been exposed to 100 /ig/ml of amphotericin B for 3 days.
The fungicidal concentration reported by Littman et al^. (1958a), O.lt
)xg/ml, however, appeared to be inconsistent with their observation that
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the minimal inhibitory concentration of amphotericin B for the same
strain of C. albicans varied from 0.09 p-g/xal at 2k hours to $ jxg/ml at
the end of 7 days. It must be considered that their fungicidal concen
tration may reflect the limitations of their sampling procedure and may
not have represented a fungicidal concentration for the entire inoculum.
The limitations of the sampling procedure used in the present broth
assay studies also may be considered as a factor in the failure to re
cover viable cells from isolate 60 after it was exposed to concentrations
greater than 10 yig/ml. However, it was possible to recover viable cells
from the remaining 5 isolates at concentrations more than 100 times
greater than the fungicidal concentration reported by Littman et al.
(I9^8a).
tones and Peacock (19?9) reported a precipitation of amphotericin
B at concentrations of 10 or 20 jig/ml of assay broth

glucose and 1%

peptone). They demonstrated that each component of the assay medium
was capable of causing flocculation of the antibiotic in the absence of
the other. In an attempt to eliminate the precipitate, they modified
their medium to contain 0,S% glucose and 0.1^ peptone. With this alter
ation they were able to prevent precipitation of the antibiotic. When
a similar medium was used in the present investigation, a precipitate
was nevertheless observed at concentrations of 10/ig/ml or more of
amphotericin B. The precipitate was not present initially but occurred
during incubation of both inoculated and uninoculated cultures for i|.8
hours at 37°C. Other investigators who have employed similar media
(Hebeka and Solotorovsky, 1965? Sorensen e;t al., 1959) have not reported
a precipitate. Their failure to observe a precipitate may have resulted
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from their use of shaken cultures which would tend to prevent any vis
ible settling of the antibiotic. The use of stationary cultures by
Lones and Peacock (19^9) and in the present study was believed to be
primarily responsible for the observation of the antibiotic precipitate»
The precipitate could, however, be visibly eliminated by shaking the
tubes and at no time altered the optical densities of the suspensions.
Since amphotericin B occurs as a colloidal suspension (Bartner

al.,

19^8), the aggregation of micelles may not effectively reduce their
fungistatic and/or fungicidal effects on the cell.
Other factors may influence the fungicidal activity of amphoteri
cin B in Sabouraud broth. Ifowever, since the same factors may also
operate in human plasma, they will be considered with the results of
the assays of fungicidal activity of the antibiotic in human plasma.
The clinical significance of the recovery of viable cells from
amphotericin B concentrations greater than 1 p.g/ml is difficult to
ascertain since the constituents and/or their concentrations in the
Sabouraud broth assay system are not directly comparable to those
present in the

vivo system.

Reports of decreased growth rates, decreased ability to form
mycelium and chlamydospores (Lones and Peacock, 19?9) and the observa
tion of pleomorphic cells (Sorensen £b al., 19^9) in amphotericin Bresistant strains of Ç, albicans prompted a reexamination of the
organism's ability to produce mycelia and/or chlamydospores during
or after exposure to amphotericin B. The inoculation of com mealtween agar with and without 2 ^g/ml of amphotericin B with 5 strains
of C. albicans and antibiotic-tolerant isolates derived from them
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demonstrated that previous exposure to amphotericin B did not affect
the ability of the organism to produce mycelium and chlamydospores on
normal com meal-tween agar. Two strains did, however, show consistent
significant differences in the amount of mycelial growth in the presence
of 2 jag/ml of amphotericin B. Chlamydospore formation per given area
of mycelium however appeared to be unaffected by the presence of the
antibiotic. It appears, therefore, that exposure of C. albicans to high
concentrations of amphotericin B does not affect the characteristics
which are used clinically to identify £. albicans î mycelium formation,
chlau^ydospore production and blastesis in human plasma. It is unlikely
that £. albicans recovered from an amphotericin B-treated case would go
unrecognized in a routine cultural examination.
The ability of £. albicans to form hyphae (filaments or germ tubes)
in human plasma |>r serum within 2 or 3 hours when incubated at 37°C has
been reported by a number of investigators (Taschjian et al., I960;
Mackenzie, D.W.R., 1962; Griffin, 196it; Dabrowa et al., 1965; Landau
et al., 1962; Bonfante and Barroeta, 1968) and is presently felt by some
(Taschdjian et al., I960; Bonfante and Barroeta, 1966) to be a rapid
and reliable imthod for identifying G, albicans in the diagnostic labor
atory. This ability was used as the criterion for determining growth
of the organism in human plasma.
Landau and coworkers (1956) reported that as the inoculum size
increases the per cent blastesis or filamentation decreases. There
fore, it is essential that the inoculum size to be used in the assay be
carefully considered. The inoculum (5 x 10^ cells/ml) which was em
ployed in this study, has been reported to undergo approximately 70%
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blastesis within 3 hours. It was therefore felt that the absence of
blastesis for U8 hours represented a reliable indication of the fungi
static activity of amphotericin B in plasma. In the present investiga
tion the relative occurrence of blastesis was not precisely quantified;
however, if it occurred in greater than about 3 percent of the cells,
which allows for a minimal carry over of germ tubes within the inoculum,
the result was considered positive. Otherwise, it was recorded as
negative.
The results of this investigation demonstrated that the fungistatic
activity of amphotericin B when based on blastesis was higher (2.0
pg/ml) in plasma than in Sabouraud broth (0.$ jig/ml). This difference
in fungistatic concentrations between the plasma and the broth systems
may in part result from the use of a more sensitive index for deter
mining growth in plasma. However, the possibility that some plasma
components may also influence the activity of amphotericin B can not
be excluded (Taschdjian and Kozinn, 1961; Heite et al., 196b; Roth et
al., 19$9; Roth and Goldstein, 1961; Louria and Brayton, 196!*; Caroline
et al., 196U; Landau et al., 196b).
Concurrent with the reduction in blastesis as the concentration
of amphotericin B increased was a decrease in the length of the germ
tube at antibiotic concentrations of 0.5 p.g/ml or more and also a de
crease in viability within the original inoculum.
Other investigators (Vogel and Crutcher, 1958; Littman et al.,
1958b; McNall et al., 1958; Gerke and Madigan, 1961) have studied the
fungistatic effects of amphotericin B on Ç. albicans and on other Can
dida species in serum and other body fluids. However, with one
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exception, their results are not directly comparable with the present
study since the criteria for growth, the assay medium diluent and other
materials and procedures were significantly different such as to render
the validity of a comparison questionable.
The only report found in the literature which included blastesis
as an indicator of the effect of amphotericin B on

albicans was that

by Landau and coworkers (1965) who used a serum assay medium. They
reported that blastesis in sera incubated for 3 hours was less than
when the amphotericin B concentration was 5 jag/ral or more, and \S%
at a concentration of 1;ig/ml, as compared to the control with 8$#.
The variation which they observed in the percentage of germination in
duplicate tests did not exceed 10^ and an average was reported as the
result.
The results reported by Landau and coworkers (196$)were determined
after 3 hours at 37°C. A 3-hour incubation period, although it is
sufficient time to demonstrate blastesis in the diagnostic laboratory,
was not considered to be a realistic time from a clinical point of
view to determine the activity of the antibiotic. In most clinical
cases, U8 hours represents the maximum time which would elapse between
infusions of the antibiotic. It was therefore decided that it would
be of more value to measure the activity of a given conaentration of
amphotericin B at this clinical limit than at a time which may not be
long enough to represent an accurate indication of its possible ^vivo
effectiveness. Secondarily, a U8-hour incubation period was considered
since it would allow comparison of results with those obtained using
the Sabouraud broth assay system.
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The fungicidal activity of amphotericin B in human plasma was
demonstrated in the present investigation to be greater than in Sabouraud broth. Viable cells were not recovered after exposure to greater
than 3 }ig/ml of amphotericin B when subcultured on blood agar. How
ever, evidence of viability could still be demonstrated if the assay
sample was diluted with sufficient trypticase soy broth to reduce the
concentration of amphotericin B below the fungistatic level. At an
amphotericin B concentration of 5^g/ml even after dilution, viability
was lost in ^0% of the samples from 3 of the it isolates of C. albicans
tested.
In the bioassay studies previously mentioned, the fungicidal
effects of amphotericin B on C. albicans in human plasma or serum were
not investigated.
In 1963, Louria and Brayton reported the presence of a candidacidal substance in human plasma and serum. The substance was reported
(Louria and Brayton, 196^) to remain active 2 weeks when refrigerated
at li°C and indefinitely when frozen at -20°C. It was therefore not
considered to influence the results of the present investigation.
Other factors which may have influenced the fungistatic and/or fungi
cidal activity of amphotericin B in plasma includes the isolate of G.
albicans employed, the size of the inoculum, the growth phase of the
inoculum (McNall et al., 1958), the duration of antibiotic contact
with the organism, and in the case of plasma, the medium itself may
contribute to the fungicidal activity observed.
The results presented here have shown that C. albicans is able
to grow in the presence of an amphotericin B concentration (1,0 /ig/ml)
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which approximates the highest in vivo concentration which can safely
be maintained for about 2k hours. However, there was a marked reduction
in viability accompanying the limited growth at 1 /ig/ml and, as demon
strated by failure to obtain subcultures on blood agar, viability was
lost at an antibiotic concentration of

jag/ml. Since the effects re

ported here represent a single contact with the antibiotic and not a
repeated contact as would occur in a clinical infection, the growth and
viability demonstrated in this study although they are of academic sig
nificance may not be of clinical significance.
]h conclusion, the plasma assay system aftpeared to demonstrate a
greater fungicidal activity of amphotericin B than did the Sabouraud
broth system. Although there was apparent growth (blastesis) of G,
albicans in plasma at an amphotericin B concentration of 1 pg/ml, the
growth was not sufficient enough to impart visible turbidity to the
plasma tubes containing 0.^ pg/ml of amphotericin B when visually com
pared to the control. It was therefore considered that the fungistatic
activity of amphotericin B in both assay systems was similar.
The effects of amphotericin B on growth of the mycelial phase of
G. albicans in Sabouraud broth or human plasma were not considered in
this investigation.
The steroid hormones ACTH, cortisone, and hydrocortisone have been
shown by a number of investigators to depress host resistance to mycotic,
bacterial and viral infections (Seligmann, 19^3; Louria e;b

, I960;

Hellman, A., 1965; Foley et al., 1957; Batten and McCune, 1957). The
mechanisms by which they lower host resistance include? a decrease in
the inflammatory response process (Ketchel et al., 1958; Menkin, 7.,

38

19^h? Michael and Whorton, 19^1), decreased antibody production
(Bj^meboe ejb aT^., 19^1; Kass et al., 1955; Siedlicka et

, 1963;

Germath and Ottinger, 1950), lymphopenia (Paluska and Hamilton, 1963)
. . . and a decreased phagocytic activity (Crepea et al., 1951).
In 1961, Boyd and Chappell reported a systemic Ç, albicans infec
tion which terminated fatally after combined steroid and antibiotic
therapy. The present study was undertaken to determine if the iraraonological depressant effects produced by the steroid hormone, hydrocor
tisone, could be over come by the administration of amphotericin B.
To determine this, the effect of hydrocortisone acetate on the course
of an induced systemic candidal infection was first investigated.
!Itie results of this investigation showed that a significant in
crease in mortality rate occurred when mice were pretreated with
hydrocortisone as compared to the control group. In Experiment 5
there was a ^0% mortality in the hydrocortisone pretreated group on
the sixth postinfectional day as compared to 12.5% in the control
group. In a second experiment (Experiment 6), on the sixth post
infectional day there was a 77% mortality in the hydrocortisone pre
treated group as compared to 22% in the control group. These studies
very clearly demonstrate the adverse effects exerted by hydrocortisone
on the course of systemic candidal infections.
Hrairy and Fahlberg in I960 reported that hydrocortisone acetate
(l to 10 mg) given as a single intraperitoneal injection 2li hours
prior to challenge with Ç. albicans by the same route did not produce
an increase in the mortality rate. However, repeated daily doses of
hydrocortisone acetate given intraperitoneally over a 2-week period
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brought about an enhancement of the candidal infection and correlated
directly with the amount of hydrocortisone acetate given. When 1.0 mg
of hydrocortisone acetate was given daily for 2 weeks, the mortality
rate in the hydrocortisone-treated group was

as compared to 13% for

the control group. Di the present study, 1.2$ mg of hydrocortisone
acetate given for L. successive days before challenge with £. albicans
was shown to produce a similar enhancement of the candidal infection
and increase in the mortality rate.
Using the immunological depressant effects of hydrocortisone ace
tate to establish a rapidly fatal systemic candidal infection, the
effect of amphotericin B on the course of this infection was investi
gated. Hie results at the termination of the experiment showed that
amphotericin B in the dose regimen employed was able to arrest the
systemic infection in both amphotericin B-treated groups. In the l8th
postinfectional day, there was 100$ mortality in both the hydrocortisoneand saline-treated infected groups as compared to a

mortality and a

55$ mortality in the hydrocortisone and control groups receiving ampho
tericin B. In this study the effects of temporary immunological depres
sion were overcome and the systemic candidal infection was arrested by
the use of amphotericin B.
The dose of amphotericin B used in the present investigation may
have accounted for the deaths observed in both infected-treated groups
as is evidenced by the kk$ mortality in both antibiotic control groups
(Figure 6). The uncomplexed form of amphotericin B when given intraperitoneally in concentrations from ^ to 100 mg/kg was reported by
Sternberg and coworkers (1956) not to produce chronic toxicity. Emmons

ko
and Piggott (1959) did not report any fatal toxicity resulting from the
administration of $6 mg/kg of crystalline amphotericin B to mice intraperitoneally. However, they did report that the same solubilized form
of the antibiotic as was used in the present study when given intra
venously produced fatal toxic effects in the control mice at a concen
tration of 2.2 mg/kg. In the present investigation the intraperitoneal
route was used in an attempt to increase the concentration of amphoter
icin B which could be given and decrease its toxic effects. Although
the intraperitoneal route was shown to increase the tolerable concen
tration of antibiotic, amphotericin B in the concentrations given still
produced serious toxic side effects.
At the termination of this experiment, autopsies performed on the
surviving normal and immune—suppressed amphotericin B-treated infected
mice—revealed macroscopic cortical kidney lesions and yeast-like cells
in a number of renal tubules. These observations together with the
death which occurred in an amphotericin B-treated mouse on the 12th
postinfectional day suggest that amphotericin B even in the high concen
trations (almost an

given to animals with normal host defense

mechanisms was not adequate to eliminate the infecting organism from
the host.
Since

albicans is capable of invading and residing within the

kidney of mice, it would appear to be capable of producing an acute
infection in the untreated animal and a chronic infection in the treated
animal. Farther research, however, is required to demonstrate this
chronic state.

Ui
%e significance of this investigation is that amphotericin B was
shown to be able to compensate when given early in the course of a
systemic candidal Infection for a temporary impaimnent of the defense
mechanisms of the afflicted host. In a clinical systemic candidal in
fection, an impairment of the host's defense mechanisms may also be
temporarily compensated for by the early administration of amphotericin
B; however, ultimately amphotericin B may be dependent to some degree
on the host's defense mechanisms, in particular the host's cellular
defense mechanisms, to complete its antimicrobial effect.

CHAPTER 71

SUMMART
Six isolates obtained from clinical infections were characterized
and identified as C. albicans.
A fungistatic concentration of amphotericin B was determined for
each of the 6 isolates of C. albicans in Sabouraud broth. The
fungistatic concentrations of amphotericin B ranged from 0,1^ jug/ml
to 0.5 pg/ml.
A fungicidal concentration of amphotericin B (10 pg/ml) was
demonstrated for only 1 (isolate 60) of the 6 isolates of C.
albicans in Sabouraud broth. Viable cells were recovered from
the remaining 5 isolates at amphotericin B concentrations as high
as 50 pg/ml.
The ability of $ isolates of G, albicans to produce mycelium and
ohlamydospores after exposure to 10 or 20jug/ml of amphotericin B
was unaltered. However, mycelium formation (but not chlamydospore
production) was reduced in 2 isolates of C, albicans (IB and $k)
when grown on com meal-tween agar in the presence of 2 ;ig/ml of
amphotericin B.
The growth of 0. albicans as well as the inhibitory activity of
amphotericin B were shown to be Influenced by the concentration of
peptone In the assay medium. In a low peptone medium (0.1%) the
growth of 2' albicans was significantly reduced and the Imhibitory
activity of amphotaricln B increased as compared to an assay medium
12

h3
with a high peptone concentration (l.O/K),
6. %e concentrations of glucose used in the assay media did not
appear significantly to affect the growth of Ç. albicans, or the
inhibitory activity of amphotericin B,
7. Using blastesis as a criterion for determining fongistatis, the
fungistatic concentration of amphotericin B was shown to be greater
in plasma (2,0 jag/ml) than in Sabouraud broth (O.lt-0,^ jig/ml) for
ij. isolates of £, albicans.
8. A fungicidal concentration of amphotericin B in plasma as measured
by the recovery of viable cells on blood agar plates was demon
strated for k isolates of £. albicans to be U jig/ml.
9. £. albicans, isolate 3A, was shown to be pathogenic for male white
mice.
10, Hydrocortisone acetate was shown to increase significantly the
mortality rate of mice infected with £, albicans.
11, Bie immunological depressant effects of hydrocortisone treatment
of infected mice were overcome and the systemic candidal infection
arrested by the use of amphotericin B.
12, There was some evidence to suggest that the concentrations of
amphotericin B used to treat the systemic candidal infection,
although toxic to some of the mice, were unable even in normal
hosts to rid the animal of the infecting organism.
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